US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 27, 2016 (11 years ago)

Menthocin Patch with Lidocaine-Strong

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed without an approved NDA/ANDA

What was recalled

Menthocin Patch with Lidocaine-Strong (Menthol 5%, Capsaicin 0.0375%, Methyl Salicylate 20%, Lidocaine 0.5%), packaged in a box 15 patches, RX Only, Manufactured for Bonita Pharmaceuticals LLC 6380 Commerce Drive Westland, MI 48185-9120, USA NDC 53598-0012-15

Recalling firm
Bonita Pharmaceuticals, LLC
NDC code
53598-0012-15
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0665-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Lidocaine recalls

See all
Class II · Moderate risk Ongoing

Xylocaine

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0729-2026
Class II · Moderate risk Ongoing

Xylocaine

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0728-2026
Class II · Moderate risk Ongoing

Lidocaine HCl Injection

Reason Presence of Particulate Matter: Hair was found in products

Fresenius Kabi USA, LLC D-0726-2026
Class III · Low risk Ongoing

Lidolog Kit

Reason Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Asclemed USA Inc. D-0713-2026
Class II · Moderate risk Ongoing

Lidocaine HCl Injection USP

Reason Lack of Assurance of Sterility

Asclemed USA Inc. D-0659-2026